Susan Hoare
London Cancer(GB)
Publications by Year
Research Areas
Estrogen and related hormone effects, Immunotherapy and Immune Responses, Retinoids in leukemia and cellular processes, Lymphoma Diagnosis and Treatment, Effects and risks of endocrine disrupting chemicals
Most-Cited Works
- → A signature motif in transcriptional co-activators mediates binding to nuclear receptors(1997)2,134 cited
- → Environmentally persistent alkylphenolic compounds are estrogenic.(1994)1,384 cited
- → Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor.(1995)759 cited
- → Estrogen Receptors α and β Form Heterodimers on DNA(1997)685 cited
- → Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization.(1990)402 cited
- → A consensus DNA-binding site for the androgen receptor.(1992)267 cited
- → Tumor Necrosis Factor α As a New Target for Renal Cell Carcinoma: Two Sequential Phase II Trials of Infliximab at Standard and High Dose(2007)247 cited
- → Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen.(1993)215 cited
- → A Phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor α Inhibitor in Patients with Metastatic Breast Cancer(2004)204 cited
- → A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer(2008)180 cited